🇺🇸 Ceterizine in United States
50 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 50
Most-reported reactions
- Pruritus — 7 reports (14%)
- Dizziness — 6 reports (12%)
- Product Quality Issue — 6 reports (12%)
- Diarrhoea — 5 reports (10%)
- Loss Of Consciousness — 5 reports (10%)
- Pain — 5 reports (10%)
- Depression — 4 reports (8%)
- Fatigue — 4 reports (8%)
- Headache — 4 reports (8%)
- Hypotension — 4 reports (8%)
Other Other approved in United States
Frequently asked questions
Is Ceterizine approved in United States?
Ceterizine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Ceterizine in United States?
Genzyme, a Sanofi Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.